Original Research

Contralateral Constrictor Dose Predicts Swallowing Function After Radiation for Head and Neck Cancer

Author and Disclosure Information

 

References


Pharyngoesophageal stricture is a common cause of dysphagia after IMRT for H&N cancer.16 Radiation has been shown to decrease pharyngeal function in patients with H&N cancer.17 Sparing one side of the pharynx may allow for better pharyngeal compliance throughout the length of the pharynx, possibly decreasing the rate of pharyngoesophageal stricture. Additionally, constraining the contralateral constrictor may preserve strength on this side, allowing it to compensate for weakness on the side of the primary cancer. An exercise sometimes used for dysphagia involves head rotation toward the affected side during swallowing. This technique has been shown to cause food to move to the unaffected side.18 Sparing the contralateral constrictor may help such techniques work better in patients with H&N cancer.

Few studies have commented specifically on dose to swallowing structures contralateral to the primary tumor. Two studies have proposed contralateral submandibular gland constraints for dysphagia (not xerostomia), but neither measured the dose to the contralateral constrictor muscle.9,10 Although the contralateral submandibular dose may correlate with dose to the constrictor on that side, the submandibular gland may have a less direct impact on swallowing than the constrictor muscle, and its limited dimensions may make constraints based on the gland less robust for cancers outside the oropharynx.

Another study reported improved quality of life in patients who were not treated with elective contralateral retropharyngeal radiation.19 Although it is likely that doses to the contralateral constrictor were lower in patients who did not receive elective radiation to this area, this study did not measure or constrain doses to the contralateral constrictors.

Limitations

This study is limited by its single institution, retrospective design, small sample size, and by all patients being male. The high correlation between air cavity editing and the use of SIB makes it impossible to assess the impact of each technique individually. Patients with contralateral constrictor V60 < 40% were less likely to have N2 disease, but N2 to N3 disease did not predict higher 1-year dysphagia, so the difference in N-category cannot fully explain the difference in 1-year dysphagia. It is possible that unreported factors, such as CTV, may contribute significantly to swallowing function. Nevertheless, within the study population, contralateral constrictor dose was able to identify a group with a low rate of long-term dysphagia.

Conclusions

Contralateral constrictor dose is a promising predictor of late dysphagia for patients with H&N cancer treated with radiation with concurrent systemic therapy. Contralateral constrictor V60 < 40% was able to identify a group of patients with a low rate of 1-year dysphagia in this single-center retrospective study. The correlation between air cavity editing and contralateral constrictor V60 suggests that contralateral constrictor dose may depend partly on technique. Further studies are needed to see if the contralateral constrictor dose can be used to predict long-term dysphagia prospectively and in other patient populations.

Pages

Recommended Reading

The Use of Aromatherapy as a Complementary Alternative Medicine in the Management of Cancer-Related Pain
AVAHO
NP-Led Suspicion of Cancer Clinic Improves Timeliness of Care for Veterans
AVAHO
Implementation of a Bone Marrow Biopsy Clinic: Effect on Wait Times for the Procedure, Diagnosis and Treatment Initiation
AVAHO
VA Launches Virtual Tumor Board
AVAHO
Novel blood test for early-stage liver cancer shows promise
AVAHO
AI tool may improve prediction of colorectal cancer recurrence
AVAHO
In VA Oncology, Discussion Groups Are Transforming the Workplace
AVAHO
VA Center Dramatically Shrinks Wait Times for Bone Marrow Biopsies
AVAHO
Pain in Cancer Survivors: Assess, Monitor, and Ask for Help
AVAHO
Consider radiologic imaging for high-risk cutaneous SCC, expert advises
AVAHO